<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="(WHO) the China office was first notified of cases of" exact="atypical pneumonia" post="in Wuhan City on 31 December 2019. AÂ viral"/>
 <result pre="the China office was first notified of cases of atypical" exact="pneumonia" post="in Wuhan City on 31 December 2019. AÂ viral"/>
 <result pre="atypical pneumonia in Wuhan City on 31 December 2019. AÂ" exact="viral" post="genome sequence of aÂ novel coronavirus, currently termed SARS-CoVâ€‘2,"/>
 <result pre="sequence of aÂ novel coronavirus, currently termed SARS-CoVâ€‘2, with aÂ" exact="disease" post="process called COVID-19 was released 1 week later via"/>
 <result pre="first identified in the 1960s, isolated from patients with mild" exact="upper" post="respiratory infections [1]. Since then, additional human coronaviruses have"/>
 <result pre="identified in the 1960s, isolated from patients with mild upper" exact="respiratory" post="infections [1]. Since then, additional human coronaviruses have been"/>
 <result pre="in the 1960s, isolated from patients with mild upper respiratory" exact="infections" post="[1]. Since then, additional human coronaviruses have been discovered,"/>
 <result pre="coronaviruses have been discovered, including the causative agents of severe" exact="acute" post="respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)."/>
 <result pre="have been discovered, including the causative agents of severe acute" exact="respiratory" post="syndrome (SARS) and Middle East respiratory syndrome (MERS). The"/>
 <result pre="been discovered, including the causative agents of severe acute respiratory" exact="syndrome" post="(SARS) and Middle East respiratory syndrome (MERS). The first"/>
 <result pre="agents of severe acute respiratory syndrome (SARS) and Middle East" exact="respiratory" post="syndrome (MERS). The first human coronaviruses identified cause approximately"/>
 <result pre="of severe acute respiratory syndrome (SARS) and Middle East respiratory" exact="syndrome" post="(MERS). The first human coronaviruses identified cause approximately one"/>
 <result pre="first human coronaviruses identified cause approximately one third of mild" exact="upper" post="respiratory infections in humans. In immunocompromised hosts and children,"/>
 <result pre="human coronaviruses identified cause approximately one third of mild upper" exact="respiratory" post="infections in humans. In immunocompromised hosts and children, however,"/>
 <result pre="coronaviruses identified cause approximately one third of mild upper respiratory" exact="infections" post="in humans. In immunocompromised hosts and children, however, they"/>
 <result pre="immunocompromised hosts and children, however, they can result in severe" exact="pneumonia" post="and bronchiolitis [1]. The SARS represented the first pandemic"/>
 <result pre="and children, however, they can result in severe pneumonia and" exact="bronchiolitis" post="[1]. The SARS represented the first pandemic of aÂ"/>
 <result pre="It started in Guangdong Province in China in 2002 [2]." exact="Severe" post="atypical cases of pneumonia emerged and quickly spread worldwide."/>
 <result pre="started in Guangdong Province in China in 2002 [2]. Severe" exact="atypical" post="cases of pneumonia emerged and quickly spread worldwide. Investigation"/>
 <result pre="Province in China in 2002 [2]. Severe atypical cases of" exact="pneumonia" post="emerged and quickly spread worldwide. Investigation by epidemiologists suggested"/>
 <result pre="such as racoon dogs and palm civets likely transmitted the" exact="disease" post="to humans. The natural hosts are bats [2]. The"/>
 <result pre="the sputum of aÂ man who died from aÂ severe" exact="respiratory" post="syndrome. The illness was subsequently termed MERS and since"/>
 <result pre="Middle East and East Africa it continues to cause human" exact="infections" post="[3]. To date, MERS has spread to 20 countries"/>
 <result pre="Hubei province, stranding 35Â million residents [6]. Currently, however, the" exact="disease" post="continues to spread. A retrospective study suggested travelling by"/>
 <result pre="cases [8]. Subsequent reports on quarantined patients have demonstrated the" exact="disease" post="can occasionally manifest past the observed 14-day isolation period."/>
 <result pre="period. Additionally, the first person in the USA with coronavirus" exact="infection" post="shed the virus in loose stool specimens, yielding concerns"/>
 <result pre="to human transmission was realized early in the SARS pandemic." exact="Primary" post="symptoms included fever, cough and dyspnea [2]. Outbreaks were"/>
 <result pre="human receptor for the SARS spike glycoprotein occurs in the" exact="lower" post="respiratory tract. Hence, most patients present with pneumonia rather"/>
 <result pre="receptor for the SARS spike glycoprotein occurs in the lower" exact="respiratory" post="tract. Hence, most patients present with pneumonia rather than"/>
 <result pre="in the lower respiratory tract. Hence, most patients present with" exact="pneumonia" post="rather than upper respiratory tract symptoms. Viral shedding occurs"/>
 <result pre="respiratory tract. Hence, most patients present with pneumonia rather than" exact="upper" post="respiratory tract symptoms. Viral shedding occurs about 10Â days"/>
 <result pre="tract. Hence, most patients present with pneumonia rather than upper" exact="respiratory" post="tract symptoms. Viral shedding occurs about 10Â days after"/>
 <result pre="patients present with pneumonia rather than upper respiratory tract symptoms." exact="Viral" post="shedding occurs about 10Â days after initial infection, when"/>
 <result pre="to aerosolization of the virus, with increased risk of iatrogenic" exact="infection" post="[2]. The MERS also causes aÂ severe atypical pneumonia,"/>
 <result pre="of iatrogenic infection [2]. The MERS also causes aÂ severe" exact="atypical pneumonia," post="but patients frequently have accompanying gastrointestinal symptoms and acute"/>
 <result pre="atypical pneumonia, but patients frequently have accompanying gastrointestinal symptoms and" exact="acute" post="renal failure. Like SARS, the human receptors for the"/>
 <result pre="pneumonia, but patients frequently have accompanying gastrointestinal symptoms and acute" exact="renal failure." post="Like SARS, the human receptors for the MERS virus"/>
 <result pre="human receptors for the MERS virus are located in the" exact="lower" post="respiratory tract, but additional receptors are found in the"/>
 <result pre="receptors for the MERS virus are located in the lower" exact="respiratory" post="tract, but additional receptors are found in the gastrointestinal"/>
 <result pre="pediatric cases are now being reported from China [11]. The" exact="adult" post="patients in the Wuhan study had aÂ mean incubation"/>
 <result pre="2.2, meaning â€œthat on average, each patient has been spreading" exact="infection" post="to 2.2 other peopleâ€� [8]. The authors report that"/>
 <result pre="analysis of the first 99Â cases of confirmed novel corona" exact="pneumonia" post="in Wuhan [12]. Infections were confirmed by obtaining throat"/>
 <result pre="99Â cases of confirmed novel corona pneumonia in Wuhan [12]." exact="Infections" post="were confirmed by obtaining throat swab specimens from all"/>
 <result pre="55.5Â years. Only aÂ slight majority of patients (51%) had" exact="chronic" post="diseases, the majority being cardiovascular or cerebrovascular diseases [12]."/>
 <result pre="majority of patients (51%) had chronic diseases, the majority being" exact="cardiovascular" post="or cerebrovascular diseases [12]. Presenting symptoms were fever in"/>
 <result pre="rhinorrhea. Only 1â€&quot;2% of patients reported nausea and vomiting, or" exact="chest" post="pain or diarrhea and 90% of patients had more"/>
 <result pre="of patients reported nausea and vomiting, or chest pain or" exact="diarrhea" post="and 90% of patients had more than one sign"/>
 <result pre="patients and 51% had aÂ decreased hemoglobin [12]. Based on" exact="chest" post="Xâ€‘ray and computed tomography (CT) results, 75% of patients"/>
 <result pre="Xâ€‘ray and computed tomography (CT) results, 75% of patients had" exact="bilateral" post="pneumonia at presentation, and 25% had unilateral pneumonia. During"/>
 <result pre="and computed tomography (CT) results, 75% of patients had bilateral" exact="pneumonia" post="at presentation, and 25% had unilateral pneumonia. During hospitalization,"/>
 <result pre="of patients had bilateral pneumonia at presentation, and 25% had" exact="unilateral" post="pneumonia. During hospitalization, 76% of patients required oxygen therapy,"/>
 <result pre="body temperature for at least 3Â days, significant improvement in" exact="respiratory" post="symptoms and completion of two consecutive negative tests of"/>
 <result pre="respiratory symptoms and completion of two consecutive negative tests of" exact="respiratory" post="respiratory pathogenic ribonucleic acid. They suggested sampling intervals of"/>
 <result pre="symptoms and completion of two consecutive negative tests of respiratory" exact="respiratory" post="pathogenic ribonucleic acid. They suggested sampling intervals of at"/>
 <result pre="can be advised [11]. A retrospective study from China analyzed" exact="chest" post="CT scans from 21 symptomatic patients with confirmed COVID-19"/>
 <result pre="retrospective study from China analyzed chest CT scans from 21" exact="symptomatic" post="patients with confirmed COVID-19 [14]. Consistent with clinical findings"/>
 <result pre="infected a patients, radiographic finding demonstrated most patients (76%) had" exact="bilateral" post="involvement on CT and in 71% more than 2"/>
 <result pre="lung lobes were involved. The most frequent CT findings included" exact="bilateral" post="pulmonary parenchymal ground-glass and consolidative pulmonary opacities (57%). Lung"/>
 <result pre="lobes were involved. The most frequent CT findings included bilateral" exact="pulmonary" post="parenchymal ground-glass and consolidative pulmonary opacities (57%). Lung consolidation"/>
 <result pre="frequent CT findings included bilateral pulmonary parenchymal ground-glass and consolidative" exact="pulmonary" post="opacities (57%). Lung consolidation was observed in 29%. Lung"/>
 <result pre="(57%). Lung consolidation was observed in 29%. Lung cavitation, discrete" exact="pulmonary" post="nodules, pleural effusions and lymphadenopathy were absent in all"/>
 <result pre="consolidation was observed in 29%. Lung cavitation, discrete pulmonary nodules," exact="pleural" post="effusions and lymphadenopathy were absent in all of the"/>
 <result pre="during the study period demonstrated mild or moderate progression of" exact="disease" post="[14]. Other clinicians in China also studied chest CT"/>
 <result pre="progression of disease [14]. Other clinicians in China also studied" exact="chest" post="CT scans and confirmed typical multilobar involvement on presentation,"/>
 <result pre="of breath and dyspnea are not severeâ€� [15]. If the" exact="disease" post="progresses, however, the patient will develop aÂ â€œwhite lungâ€�"/>
 <result pre="progresses, however, the patient will develop aÂ â€œwhite lungâ€� with" exact="diffuse" post="alveolar damage involving multiple lobes [15]. The clinical characteristics"/>
 <result pre="lobes [15]. The clinical characteristics associated with the development of" exact="acute" post="respiratory distress syndrome (ARDS) and death after admission for"/>
 <result pre="[15]. The clinical characteristics associated with the development of acute" exact="respiratory" post="distress syndrome (ARDS) and death after admission for COVID-19"/>
 <result pre="clinical characteristics associated with the development of acute respiratory distress" exact="syndrome" post="(ARDS) and death after admission for COVID-19 were recently"/>
 <result pre="recently described in aÂ retrospective cohort study [16]. Older age," exact="hypertension" post="and development of fever greater than 39â€¯Â°C was associated"/>
 <result pre="Increasingly, it is recognized that other organ systems, besides the" exact="pulmonary" post="system, can be adversely affected by infection with SARS-CoVâ€‘2."/>
 <result pre="systems, besides the pulmonary system, can be adversely affected by" exact="infection" post="with SARS-CoVâ€‘2. AÂ retrospective, observational analysis of 214 confirmed"/>
 <result pre="studied those with severe pneumonia, using criteria established by the" exact="American" post="Thoracic Society [17]. Of those patients with severe pneumonia,"/>
 <result pre="those with severe pneumonia, using criteria established by the American" exact="Thoracic" post="Society [17]. Of those patients with severe pneumonia, 36.4%"/>
 <result pre="severe pneumonia, 36.4% had neurological manifestations of disease, such as" exact="acute" post="cerebrovascular disease (5.7%), impaired consciousness (14.8%) and skeletal muscle"/>
 <result pre="pneumonia, 36.4% had neurological manifestations of disease, such as acute" exact="cerebrovascular disease" post="(5.7%), impaired consciousness (14.8%) and skeletal muscle injury (19.3%)."/>
 <result pre="36.4% had neurological manifestations of disease, such as acute cerebrovascular" exact="disease" post="(5.7%), impaired consciousness (14.8%) and skeletal muscle injury (19.3%)."/>
 <result pre="as acute cerebrovascular disease (5.7%), impaired consciousness (14.8%) and skeletal" exact="muscle" post="injury (19.3%). Coagulation disorders and cardiac manifestations of COVID-19"/>
 <result pre="muscle injury (19.3%). Coagulation disorders and cardiac manifestations of COVID-19" exact="infection" post="have also been reported [18, 19]. Recommendations to prevent"/>
 <result pre="of measures designed to prevent the nosocomial spread of the" exact="disease" post="[20]. They stressed the importance of identifying and isolating"/>
 <result pre="with SARS-CoVâ€‘2 early. Currently, suspicion requires fever and symptoms of" exact="respiratory" post="illness. With recent community spread, identifiable links to the"/>
 <result pre="discern and aÂ high index of suspicion should be maintained." exact="Failure" post="to identify infected patients has led to preventable dissemination"/>
 <result pre="has led to preventable dissemination in prior pandemics [21]. The" exact="primary" post="method of transmission for SARS-CoVâ€‘2 is via contact/droplet spread,"/>
 <result pre="of transmission for SARS-CoVâ€‘2 is via contact/droplet spread, related to" exact="respiratory" post="conditions; however, as with SARS, airborne transmission can occur."/>
 <result pre="advises placing patients with confirmed COVID-19 or patients with suspected" exact="infection" post="who are ill, in airborne isolation. Anterooms with space"/>
 <result pre="after removal of protective equipment. Wax and Christian advised that" exact="infection" post="control coaches should be used in some circumstances of"/>
 <result pre="patient with resuscitation interventions that have aÂ low risk of" exact="viral" post="transmission, such as placing an oral airway, placing an"/>
 <result pre="oral airway, placing an oxygen mask with an exhalation filter," exact="chest" post="compressions, defibrillation and cardioversion, obtaining intravenous or intraosseous access"/>
 <result pre="risk interventions which may generate aerosol and increase risk for" exact="infection" post="to staff and nosocomial spread include high flow nasal"/>
 <result pre="nasal cannula delivery systems may cause an increased risk of" exact="viral" post="spread and practitioners should consider avoidance of humidified oxygen"/>
 <result pre="When collecting body fluid samples, latex gloves, impermeable clothing and" exact="respiratory" post="hood should be used when needed to prevent contamination"/>
 <result pre="been approved for clinical use, although inhibitors designed to treat" exact="infections" post="in vivo are being developed. In order to increase"/>
 <result pre="of current antiviral drugs and medications used to treat other" exact="infections" post="or other disease states. The second approach is to"/>
 <result pre="drugs and medications used to treat other infections or other" exact="disease" post="states. The second approach is to develop novel agents"/>
 <result pre="were less likely to develop ARDS, and death rates were" exact="lower" post="than those treated with ribavirin and aÂ corticosteroid [1]."/>
 <result pre="SARS patients suggested that those given steroids early in the" exact="infection" post="developed prolonged viremia. Finally, patients with MERS who were"/>
 <result pre="models, when used for prophylaxis and treatment, it showed improved" exact="pulmonary" post="lung function values, reduced lung viral loads and lung"/>
 <result pre="treatment, it showed improved pulmonary lung function values, reduced lung" exact="viral" post="loads and lung pathology findings on post-mortem examination [3]."/>
 <result pre="The authors concluded â€œour work suggests that remdesivir may improve" exact="disease" post="outcomes in coronavirus patients, serve to protect health care"/>
 <result pre="of remdesivir against coronaviruses. This group showed that remdesivir inhibited" exact="virus infection" post="efficiently in aÂ human cell line sensitive to SARS-CoVâ€‘2"/>
 <result pre="remdesivir against coronaviruses. This group showed that remdesivir inhibited virus" exact="infection" post="efficiently in aÂ human cell line sensitive to SARS-CoVâ€‘2"/>
 <result pre="and chloroquine are highly effective in the control of COVID-19" exact="infection" post="in vitro.â€� They further suggested both should be assessed"/>
 <result pre="however, oral oseltamivir has been used in patients with COVID-19" exact="infections" post="in China, but to date, there is no convincing"/>
 <result pre="technologies [2]. Other groups are attempting to construct vaccines using" exact="viral" post="vectors and vaccines directed at subunits [2]. Despite worldwide"/>
 <result pre="lopinavir,ritonavir, and interferon beta against MERS-CoVNat Comm202010.1038/s41467-019-13940-6/www.nature.com/nature 4.WHO. Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). 2018. https://www.who.intemergencies/mers-cov/en/. Accessed 21 Feb 2020."/>
 <result pre="and interferon beta against MERS-CoVNat Comm202010.1038/s41467-019-13940-6/www.nature.com/nature 4.WHO. Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). 2018. https://www.who.intemergencies/mers-cov/en/. Accessed 21 Feb 2020. 5.ChoJKangJHaYet"/>
 <result pre="of novel corona-infected pneumoniaN Engl J Med202010.1056/NEJMoa2001316 9.RouthCShunkMSothmannPTransmission of 2019-ncoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med202010.1056/NEJMc2001468"/>
 <result pre="Engl J Med202010.1056/NEJMoa200119132320565 11.ChenZFuJShuQet al.Diagnosis and treatment recommendations for pediatric" exact="respiratory" post="infection caused by the 2019 novel coronavirusWorld J Ped202010.1007/s12519-020-00345-5"/>
 <result pre="J Med202010.1056/NEJMoa200119132320565 11.ChenZFuJShuQet al.Diagnosis and treatment recommendations for pediatric respiratory" exact="infection" post="caused by the 2019 novel coronavirusWorld J Ped202010.1007/s12519-020-00345-5 12.NanshanCZhouMDongXet"/>
 <result pre="clinical characteristics of 99 cases of 2019 novel corona virus" exact="pneumonia" post="in Wuhan, China: aÂ descriptive studyLancet202010.1016/S0140-6736(20)30211-7 13.HuangCWangYLiXet al.Clinical features"/>
 <result pre="in patients with 2019-nCoVEur Rad202010.1007/s00330-020-06713-z 16.WuCChenXCaiYet al.Risk factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with Coronavirus"/>
 <result pre="patients with 2019-nCoVEur Rad202010.1007/s00330-020-06713-z 16.WuCChenXCaiYet al.Risk factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with Coronavirus Disease"/>
 <result pre="2019-nCoVEur Rad202010.1007/s00330-020-06713-z 16.WuCChenXCaiYet al.Risk factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with Coronavirus Disease 2019 pneumonia"/>
 <result pre="acute respiratory distress syndrome and death in patients with Coronavirus" exact="Disease" post="2019 pneumonia in Wuhan, ChinaJAMA Int Med202010.1001/jaminternalmed.2020.0994 17.MaoLJinHHuYet al.Neurological"/>
 <result pre="distress syndrome and death in patients with Coronavirus Disease 2019" exact="pneumonia" post="in Wuhan, ChinaJAMA Int Med202010.1001/jaminternalmed.2020.0994 17.MaoLJinHHuYet al.Neurological manifestations of"/>
 <result pre="Int Med202010.1001/jaminternalmed.2020.0994 17.MaoLJinHHuYet al.Neurological manifestations of hospitalized patients with Coronacirus" exact="Disease" post="2019 in Wuhan, ChinaJAMA Neurol202010.1001/jamaneurol.2020.11277149362 18.ZhangYXiaoMZhangSet al.Coagulopathy and antiphospholipid"/>
 <result pre="J Med202010.1056/NEJMc200757532374959 19.InciardiRLupiLZacconeGet al.Cardiac involvement in aÂ patient with Coronavirus" exact="Disease" post="2019 (COVID-19)JAMA Cardiol202010.1001/jamacardio.2020.109632219357 20.WaxRChristianMPractical recommendations for critical care and"/>
 <result pre="the 2019-new coronavirus (2019-nCoV)Biosci Trends202010.5582/bst.2020.0102032389941 26.SandersJMonogueMJodlowskiTet al.Pharmacologic treatments for Coronavirus" exact="disease" post="2019 (COVID-19) A reviewJAMA202010.1001/jama2020.601932282022"/>
</results>
